The global Small Molecule API Development Service market was valued at US$ 1817 million in 2023 and is anticipated to reach US$ 2842.3 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
The small molecule API development service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for small molecule drugs, advancements in drug discovery and development technologies, and the rising prevalence of chronic diseases.The market for small molecule API development services is expected to be dominated by North America and Europe. These regions have a well-established pharmaceutical industry and a high demand for innovative drugs. Additionally, the presence of major pharmaceutical companies and contract research organizations (CROs) in these regions further contributes to their market dominance.The small molecule API development service market is highly competitive and fragmented. There are several key players operating in the market, including CROs, contract manufacturing organizations (CMOs), and pharmaceutical companies. These players compete based on factors such as price, quality, and service offerings. However, some large CROs and CMOs have a significant market share due to their extensive capabilities and expertise in small molecule API development.There are several opportunities for growth in the small molecule API development service market. The increasing focus on personalized medicine and targeted therapies presents opportunities for the development of small molecule APIs tailored to specific patient populations. Additionally, the growing demand for generic drugs and the expiration of patents for blockbuster drugs create opportunities for the development of generic small molecule APIs.Despite the growth prospects, the small molecule API development service market faces certain challenges. The high cost of drug development and the stringent regulatory requirements pose challenges for market players. Additionally, the increasing complexity of drug targets and the need for innovative technologies for drug discovery and development present challenges for small molecule API development.
This report aims to provide a comprehensive presentation of the global market for Small Molecule API Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule API Development Service.
Report Scope
The Small Molecule API Development Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule API Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule API Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Patheon
Eurofins
CordenPharma
pfizer
BOC Science
Recipharm
Cambrex
Aji Bio-Pharma
Lonza
Asymchem
Catalent
Esteve
Evonik
PCI
Syngene
Almac
Sterling
Onyx Scientific
Regis Technologies
Novasep
ChemPartner
Pharmaron
STA Pharmaceutical
Solvias
Aurigene
WuXi AppTec
Merck Millipore
Minakem
Woodstock Sterile Solutions
ICON plc
BioVectra
Lysis Pharma
Ash Stevens
Segment by Type
Chemical API
Biological API
Segment by Application
Pharmaceutical Factory
Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule API Development Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule API Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical API
1.2.3 Biological API
1.3 Market by Application
1.3.1 Global Small Molecule API Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Factory
1.3.3 Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule API Development Service Market Perspective (2019-2030)
2.2 Small Molecule API Development Service Growth Trends by Region
2.2.1 Global Small Molecule API Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule API Development Service Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule API Development Service Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule API Development Service Market Dynamics
2.3.1 Small Molecule API Development Service Industry Trends
2.3.2 Small Molecule API Development Service Market Drivers
2.3.3 Small Molecule API Development Service Market Challenges
2.3.4 Small Molecule API Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule API Development Service Players by Revenue
3.1.1 Global Top Small Molecule API Development Service Players by Revenue (2019-2024)
3.1.2 Global Small Molecule API Development Service Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule API Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule API Development Service Revenue
3.4 Global Small Molecule API Development Service Market Concentration Ratio
3.4.1 Global Small Molecule API Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule API Development Service Revenue in 2023
3.5 Small Molecule API Development Service Key Players Head office and Area Served
3.6 Key Players Small Molecule API Development Service Product Solution and Service
3.7 Date of Enter into Small Molecule API Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule API Development Service Breakdown Data by Type
4.1 Global Small Molecule API Development Service Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule API Development Service Forecasted Market Size by Type (2025-2030)
5 Small Molecule API Development Service Breakdown Data by Application
5.1 Global Small Molecule API Development Service Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule API Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule API Development Service Market Size (2019-2030)
6.2 North America Small Molecule API Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule API Development Service Market Size by Country (2019-2024)
6.4 North America Small Molecule API Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule API Development Service Market Size (2019-2030)
7.2 Europe Small Molecule API Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule API Development Service Market Size by Country (2019-2024)
7.4 Europe Small Molecule API Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule API Development Service Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule API Development Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule API Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule API Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule API Development Service Market Size (2019-2030)
9.2 Latin America Small Molecule API Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule API Development Service Market Size by Country (2019-2024)
9.4 Latin America Small Molecule API Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule API Development Service Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule API Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule API Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule API Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Patheon
11.1.1 Thermo Fisher Scientific Patheon Company Detail
11.1.2 Thermo Fisher Scientific Patheon Business Overview
11.1.3 Thermo Fisher Scientific Patheon Small Molecule API Development Service Introduction
11.1.4 Thermo Fisher Scientific Patheon Revenue in Small Molecule API Development Service Business (2019-2024)
11.1.5 Thermo Fisher Scientific Patheon Recent Development
11.2 Eurofins
11.2.1 Eurofins Company Detail
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Small Molecule API Development Service Introduction
11.2.4 Eurofins Revenue in Small Molecule API Development Service Business (2019-2024)
11.2.5 Eurofins Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Detail
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Small Molecule API Development Service Introduction
11.3.4 CordenPharma Revenue in Small Molecule API Development Service Business (2019-2024)
11.3.5 CordenPharma Recent Development
11.4 pfizer
11.4.1 pfizer Company Detail
11.4.2 pfizer Business Overview
11.4.3 pfizer Small Molecule API Development Service Introduction
11.4.4 pfizer Revenue in Small Molecule API Development Service Business (2019-2024)
11.4.5 pfizer Recent Development
11.5 BOC Science
11.5.1 BOC Science Company Detail
11.5.2 BOC Science Business Overview
11.5.3 BOC Science Small Molecule API Development Service Introduction
11.5.4 BOC Science Revenue in Small Molecule API Development Service Business (2019-2024)
11.5.5 BOC Science Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Small Molecule API Development Service Introduction
11.6.4 Recipharm Revenue in Small Molecule API Development Service Business (2019-2024)
11.6.5 Recipharm Recent Development
11.7 Cambrex
11.7.1 Cambrex Company Detail
11.7.2 Cambrex Business Overview
11.7.3 Cambrex Small Molecule API Development Service Introduction
11.7.4 Cambrex Revenue in Small Molecule API Development Service Business (2019-2024)
11.7.5 Cambrex Recent Development
11.8 Aji Bio-Pharma
11.8.1 Aji Bio-Pharma Company Detail
11.8.2 Aji Bio-Pharma Business Overview
11.8.3 Aji Bio-Pharma Small Molecule API Development Service Introduction
11.8.4 Aji Bio-Pharma Revenue in Small Molecule API Development Service Business (2019-2024)
11.8.5 Aji Bio-Pharma Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Small Molecule API Development Service Introduction
11.9.4 Lonza Revenue in Small Molecule API Development Service Business (2019-2024)
11.9.5 Lonza Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Detail
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Small Molecule API Development Service Introduction
11.10.4 Asymchem Revenue in Small Molecule API Development Service Business (2019-2024)
11.10.5 Asymchem Recent Development
11.11 Catalent
11.11.1 Catalent Company Detail
11.11.2 Catalent Business Overview
11.11.3 Catalent Small Molecule API Development Service Introduction
11.11.4 Catalent Revenue in Small Molecule API Development Service Business (2019-2024)
11.11.5 Catalent Recent Development
11.12 Esteve
11.12.1 Esteve Company Detail
11.12.2 Esteve Business Overview
11.12.3 Esteve Small Molecule API Development Service Introduction
11.12.4 Esteve Revenue in Small Molecule API Development Service Business (2019-2024)
11.12.5 Esteve Recent Development
11.13 Evonik
11.13.1 Evonik Company Detail
11.13.2 Evonik Business Overview
11.13.3 Evonik Small Molecule API Development Service Introduction
11.13.4 Evonik Revenue in Small Molecule API Development Service Business (2019-2024)
11.13.5 Evonik Recent Development
11.14 PCI
11.14.1 PCI Company Detail
11.14.2 PCI Business Overview
11.14.3 PCI Small Molecule API Development Service Introduction
11.14.4 PCI Revenue in Small Molecule API Development Service Business (2019-2024)
11.14.5 PCI Recent Development
11.15 Syngene
11.15.1 Syngene Company Detail
11.15.2 Syngene Business Overview
11.15.3 Syngene Small Molecule API Development Service Introduction
11.15.4 Syngene Revenue in Small Molecule API Development Service Business (2019-2024)
11.15.5 Syngene Recent Development
11.16 Almac
11.16.1 Almac Company Detail
11.16.2 Almac Business Overview
11.16.3 Almac Small Molecule API Development Service Introduction
11.16.4 Almac Revenue in Small Molecule API Development Service Business (2019-2024)
11.16.5 Almac Recent Development
11.17 Sterling
11.17.1 Sterling Company Detail
11.17.2 Sterling Business Overview
11.17.3 Sterling Small Molecule API Development Service Introduction
11.17.4 Sterling Revenue in Small Molecule API Development Service Business (2019-2024)
11.17.5 Sterling Recent Development
11.18 Onyx Scientific
11.18.1 Onyx Scientific Company Detail
11.18.2 Onyx Scientific Business Overview
11.18.3 Onyx Scientific Small Molecule API Development Service Introduction
11.18.4 Onyx Scientific Revenue in Small Molecule API Development Service Business (2019-2024)
11.18.5 Onyx Scientific Recent Development
11.19 Regis Technologies
11.19.1 Regis Technologies Company Detail
11.19.2 Regis Technologies Business Overview
11.19.3 Regis Technologies Small Molecule API Development Service Introduction
11.19.4 Regis Technologies Revenue in Small Molecule API Development Service Business (2019-2024)
11.19.5 Regis Technologies Recent Development
11.20 Novasep
11.20.1 Novasep Company Detail
11.20.2 Novasep Business Overview
11.20.3 Novasep Small Molecule API Development Service Introduction
11.20.4 Novasep Revenue in Small Molecule API Development Service Business (2019-2024)
11.20.5 Novasep Recent Development
11.21 ChemPartner
11.21.1 ChemPartner Company Detail
11.21.2 ChemPartner Business Overview
11.21.3 ChemPartner Small Molecule API Development Service Introduction
11.21.4 ChemPartner Revenue in Small Molecule API Development Service Business (2019-2024)
11.21.5 ChemPartner Recent Development
11.22 Pharmaron
11.22.1 Pharmaron Company Detail
11.22.2 Pharmaron Business Overview
11.22.3 Pharmaron Small Molecule API Development Service Introduction
11.22.4 Pharmaron Revenue in Small Molecule API Development Service Business (2019-2024)
11.22.5 Pharmaron Recent Development
11.23 STA Pharmaceutical
11.23.1 STA Pharmaceutical Company Detail
11.23.2 STA Pharmaceutical Business Overview
11.23.3 STA Pharmaceutical Small Molecule API Development Service Introduction
11.23.4 STA Pharmaceutical Revenue in Small Molecule API Development Service Business (2019-2024)
11.23.5 STA Pharmaceutical Recent Development
11.24 Solvias
11.24.1 Solvias Company Detail
11.24.2 Solvias Business Overview
11.24.3 Solvias Small Molecule API Development Service Introduction
11.24.4 Solvias Revenue in Small Molecule API Development Service Business (2019-2024)
11.24.5 Solvias Recent Development
11.25 Aurigene
11.25.1 Aurigene Company Detail
11.25.2 Aurigene Business Overview
11.25.3 Aurigene Small Molecule API Development Service Introduction
11.25.4 Aurigene Revenue in Small Molecule API Development Service Business (2019-2024)
11.25.5 Aurigene Recent Development
11.26 WuXi AppTec
11.26.1 WuXi AppTec Company Detail
11.26.2 WuXi AppTec Business Overview
11.26.3 WuXi AppTec Small Molecule API Development Service Introduction
11.26.4 WuXi AppTec Revenue in Small Molecule API Development Service Business (2019-2024)
11.26.5 WuXi AppTec Recent Development
11.27 Merck Millipore
11.27.1 Merck Millipore Company Detail
11.27.2 Merck Millipore Business Overview
11.27.3 Merck Millipore Small Molecule API Development Service Introduction
11.27.4 Merck Millipore Revenue in Small Molecule API Development Service Business (2019-2024)
11.27.5 Merck Millipore Recent Development
11.28 Minakem
11.28.1 Minakem Company Detail
11.28.2 Minakem Business Overview
11.28.3 Minakem Small Molecule API Development Service Introduction
11.28.4 Minakem Revenue in Small Molecule API Development Service Business (2019-2024)
11.28.5 Minakem Recent Development
11.29 Woodstock Sterile Solutions
11.29.1 Woodstock Sterile Solutions Company Detail
11.29.2 Woodstock Sterile Solutions Business Overview
11.29.3 Woodstock Sterile Solutions Small Molecule API Development Service Introduction
11.29.4 Woodstock Sterile Solutions Revenue in Small Molecule API Development Service Business (2019-2024)
11.29.5 Woodstock Sterile Solutions Recent Development
11.30 ICON plc
11.30.1 ICON plc Company Detail
11.30.2 ICON plc Business Overview
11.30.3 ICON plc Small Molecule API Development Service Introduction
11.30.4 ICON plc Revenue in Small Molecule API Development Service Business (2019-2024)
11.30.5 ICON plc Recent Development
11.31 BioVectra
11.31.1 BioVectra Company Detail
11.31.2 BioVectra Business Overview
11.31.3 BioVectra Small Molecule API Development Service Introduction
11.31.4 BioVectra Revenue in Small Molecule API Development Service Business (2019-2024)
11.31.5 BioVectra Recent Development
11.32 Lysis Pharma
11.32.1 Lysis Pharma Company Detail
11.32.2 Lysis Pharma Business Overview
11.32.3 Lysis Pharma Small Molecule API Development Service Introduction
11.32.4 Lysis Pharma Revenue in Small Molecule API Development Service Business (2019-2024)
11.32.5 Lysis Pharma Recent Development
11.33 Ash Stevens
11.33.1 Ash Stevens Company Detail
11.33.2 Ash Stevens Business Overview
11.33.3 Ash Stevens Small Molecule API Development Service Introduction
11.33.4 Ash Stevens Revenue in Small Molecule API Development Service Business (2019-2024)
11.33.5 Ash Stevens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific Patheon
Eurofins
CordenPharma
pfizer
BOC Science
Recipharm
Cambrex
Aji Bio-Pharma
Lonza
Asymchem
Catalent
Esteve
Evonik
PCI
Syngene
Almac
Sterling
Onyx Scientific
Regis Technologies
Novasep
ChemPartner
Pharmaron
STA Pharmaceutical
Solvias
Aurigene
WuXi AppTec
Merck Millipore
Minakem
Woodstock Sterile Solutions
ICON plc
BioVectra
Lysis Pharma
Ash Stevens
听
听
*If Applicable.